skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:057988/0232   Pages: 16
Recorded: 10/04/2021
Attorney Dkt #:138179-011700
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 23
1
Patent #:
NONE
Issue Dt:
Application #:
15319738
Filing Dt:
12/16/2016
Publication #:
US20170151339
Pub Dt:
06/01/2017
PCT #:
US2015038562
Title:
TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
2
Patent #:
9750818
Issue Dt:
09/05/2017
Application #:
15382487
Filing Dt:
12/16/2016
Publication #:
US20170095569
Pub Dt:
04/06/2017
Title:
TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
3
Patent #:
10624967
Issue Dt:
04/21/2020
Application #:
15652947
Filing Dt:
07/18/2017
Publication #:
US20180000959
Pub Dt:
01/04/2018
Title:
TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
4
Patent #:
10322191
Issue Dt:
06/18/2019
Application #:
15652957
Filing Dt:
07/18/2017
Publication #:
US20170312245
Pub Dt:
11/02/2017
Title:
TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
5
Patent #:
NONE
Issue Dt:
Application #:
15734110
Filing Dt:
12/01/2020
Publication #:
US20210186978
Pub Dt:
06/24/2021
Title:
COMBINATION THERAPY
6
Patent #:
NONE
Issue Dt:
Application #:
15749180
Filing Dt:
01/31/2018
Publication #:
US20180221503
Pub Dt:
08/09/2018
PCT #:
US2016044775
Title:
COMPOSITIONS AND METHODS FOR IMMUNO-ONCOLOGY THERAPIES
7
Patent #:
NONE
Issue Dt:
Application #:
15749194
Filing Dt:
01/31/2018
Publication #:
US20180221508
Pub Dt:
08/09/2018
PCT #:
US2016044705
Title:
COMPOSITIONS AND METHODS FOR IMMUNOMODULATION
8
Patent #:
11160871
Issue Dt:
11/02/2021
Application #:
15770513
Filing Dt:
04/24/2018
Publication #:
US20180221499
Pub Dt:
08/09/2018
Title:
SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
9
Patent #:
10548881
Issue Dt:
02/04/2020
Application #:
16079387
Filing Dt:
08/23/2018
Publication #:
US20190054072
Pub Dt:
02/21/2019
Title:
HSP90 TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
10
Patent #:
11213590
Issue Dt:
01/04/2022
Application #:
16345306
Filing Dt:
04/26/2019
Publication #:
US20190262460
Pub Dt:
08/29/2019
Title:
SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
11
Patent #:
11241500
Issue Dt:
02/08/2022
Application #:
16469768
Filing Dt:
06/14/2019
Publication #:
US20200085960
Pub Dt:
03/19/2020
Title:
HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF
12
Patent #:
NONE
Issue Dt:
Application #:
16625358
Filing Dt:
12/20/2019
Publication #:
US20200230126
Pub Dt:
07/23/2020
Title:
TARGETED THERAPEUTICS
13
Patent #:
NONE
Issue Dt:
Application #:
16625362
Filing Dt:
12/20/2019
Publication #:
US20200230247
Pub Dt:
07/23/2020
Title:
COMBINATION THERAPIES COMPRISING TARGETED THERAPEUTICS
14
Patent #:
NONE
Issue Dt:
Application #:
16625368
Filing Dt:
12/20/2019
Publication #:
US20200237746
Pub Dt:
07/30/2020
Title:
HSP90 TARGETED CONJUGATES AND PARTICLE FORMULATIONS THEREOF
15
Patent #:
11510910
Issue Dt:
11/29/2022
Application #:
16711577
Filing Dt:
12/12/2019
Publication #:
US20200113877
Pub Dt:
04/16/2020
Title:
HSP90 TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
16
Patent #:
NONE
Issue Dt:
Application #:
16722913
Filing Dt:
12/20/2019
Publication #:
US20200121808
Pub Dt:
04/23/2020
Title:
SSTR-TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF
17
Patent #:
NONE
Issue Dt:
Application #:
16759438
Filing Dt:
04/27/2020
Publication #:
US20200281934
Pub Dt:
09/10/2020
Title:
SSTR-TARGETED CONJUGATES AND FORMULATIONS THEREOF
18
Patent #:
NONE
Issue Dt:
Application #:
16772290
Filing Dt:
06/12/2020
Publication #:
US20210000966
Pub Dt:
01/07/2021
Title:
HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF
19
Patent #:
11458206
Issue Dt:
10/04/2022
Application #:
16793094
Filing Dt:
02/18/2020
Publication #:
US20200206356
Pub Dt:
07/02/2020
Title:
TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
20
Patent #:
NONE
Issue Dt:
Application #:
17045320
Filing Dt:
10/05/2020
Publication #:
US20210145971
Pub Dt:
05/20/2021
Title:
HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF
21
Patent #:
NONE
Issue Dt:
Application #:
17045325
Filing Dt:
10/05/2020
Publication #:
US20210169871
Pub Dt:
06/10/2021
Title:
PHARMACEUTICAL COMPOSITIONS WITH REDUCED TERT-BUTANOL LEVELS
22
Patent #:
NONE
Issue Dt:
Application #:
17275748
Filing Dt:
03/12/2021
Publication #:
US20220031853
Pub Dt:
02/03/2022
PCT #:
US2019050916
Title:
HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF
23
Patent #:
NONE
Issue Dt:
Application #:
17600692
Filing Dt:
10/01/2021
Publication #:
US20220184217
Pub Dt:
06/16/2022
PCT #:
US2020026137
Title:
HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF
Assignor
1
TARVEDA THERAPEUTICS, INC.
Exec Dt:
09/30/2021
Assignee
1
OXFORD FINANCE LLC
115 SOUTH UNION STREET, SUITE 3000
ALEXANDRIA, VIRGINIA 22314
Correspondence name and address
EUGENIA A. PREZAS
GREENBERG TRAURIG, LLP
ONE INTERNATIONAL PLACE, SUITE 2000
BOSTON, MA 02110

Search Results as of: 05/29/2024 07:28 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT